Advocacy intelligence hub — real-time data for patient organizations
Boehringer Ingelheim — PHASE1
Natera, Inc.
Imperial College London
LigaChem Biosciences, Inc. — PHASE1, PHASE2
AstraZeneca — PHASE1, PHASE2
University Health Network, Toronto
Tata Memorial Centre — NA
Memorial Sloan Kettering Cancer Center — NA
BioInvent International AB — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Matthew Krebs, Dr
The Christie Hospital
Lillian Siu, MD
Princess Margaret Hospital, Canada
Yoshiya Yamada, MD, MD
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
Stanislaw R. Burzynski, MD, PhD, M.D., Ph.D
Burzynski Research Institute
📍 HOUSTON, TX
Kris Ann P Schultz, MD
Children's Minnesota
James L Gulley, M.D., MD PhD FACP
National Cancer Institute (NCI)
📍 BETHESDA, MD